Splice Bio Overview

  • Founded
  • 2012
  • Status
  • Private
  • Employees
  • 9
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $3.91M
Latest Deal Amount
  • Investors
  • 8

Splice Bio General Information


Developer of a novel platform technology designed to help in protein engineering. The company's technology uses proprietary conjugation technologies that help in the development and production of a preferred class of biotherapeutics, including antibody-drug conjugates, overcoming limitations of the currently used methods, enabling biotech companies to develop biological drugs and improve patients' quality of life.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • Baldiri Reixac, 10-12
  • 08028 Barcelona
  • Spain
+34 934 00 00 00

Splice Bio Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Splice Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 22-Jun-2020 $3.91M 00.000 Completed Generating Revenue
4. Later Stage VC (Series A) 12-Dec-2017 00.000 00.000 Completed Generating Revenue
3. Grant 28-Nov-2015 Completed Generating Revenue
2. Seed Round 20-Apr-2015 Completed Generating Revenue
1. Seed Round 13-Dec-2014 Completed Generating Revenue
To view Splice Bio’s complete valuation and funding history, request access »

Splice Bio Executive Team (4)

Name Title Board Seat Contact Info
Miquel Vila-Perelló Ph.D Co-Founder, Chief Executive Officer & CSO
Silvia Frutos Ph.D Co-Founder, Chief Technology Officer & Chief Operating Officer
Gerard Caelles Chief Business Officer & Director, Business Development
Marc Litchfield Co-Founder & Board Member
To view Splice Bio’s complete executive team members history, request access »

Splice Bio Board Members (7)

Name Representing Role Since
Alex Casta Ruiz Ph.D Splice Bio Board Member 000 0000
Jose Antonio Mesa Cejudo Splice Bio Board Member 000 0000
Marc Litchfield Splice Bio Co-Founder & Board Member 000 0000
Pablo Cironi Ph.D Caixa Capital Risc Board Member 000 0000
Thomas Muir Ph.D Self Co-Founder, Scientific Advisor & Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Splice Bio Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Splice Bio Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Asabys Partners Venture Capital Minority 000 0000 000000 0
Ysios Capital Venture Capital Minority 000 0000 000000 0
Blue Compass Venture Capital Minority 000 0000 000000 0
ACC1O Government 000 0000 000000 0
Empresa Nacional de Innovación Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »